CCM® Overview - Patient Education

639 views
September 1, 2020

This animation provides discusses heart failure symptoms and treatment options.  CCM therapy is introduced including the indications for use, recommendations for patient selection, and a brief description of how cardiac contractility works in the heart.  The procedure is reviewed as well as clinical trial results.

  • October 26, 2021 - U.S. Food and Drug Administration approved a modification of labeling for the Optimizer® Smart medical device, allowing the removal of “normal sinus rhythm” (NSR) from the indications for use statement as of 10/26/2021. Please note that this presentation was done prior to this FDA update.
0 Comments
Login to view comments. Click here to Login